Review summarizes fenofibrate, metformin, and MSC modulation in Primary Sjögren disease management.
The Dry Mouth Disease Has an Immune Fix Researchers Didn't Expect
This review examines the potential of fenofibrate, metformin, and mesenchymal stem cells in Primary Sjögren disease management. Authors sugg…
Three existing drugs may restore the immune balance broken in Sjögren's disease, a chronic condition that destroys saliva and tear glands.
PPARα rs6008845 genotype modifies fenofibrate benefit for vascular events in type 2 diabetes
Genetic variant linked to diabetes risks and fenofibrate benefits in FIELD study
This RCT substudy of 8,159 adults with type 2 diabetes examined the PPARα rs6008845 genotype and fenofibrate treatment. Participants carryin…
A specific gene variant increases diabetes complication risks, but fenofibrate treatment benefits remain consistent across all genetic group…